Rapid report 2: Symptoms of anxiety and depression during the first 12 weeks of the Coronavirus (COVID-19) pandemic in Australia.
Anxiety
COVID-19
Depression
Internet
Mental health
Service implementation
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
24
07
2020
revised:
12
10
2020
accepted:
14
10
2020
pubmed:
29
10
2020
medline:
29
10
2020
entrez:
28
10
2020
Statut:
ppublish
Résumé
The MindSpot Clinic, funded by the Australian Government, is a national digital mental health service (DMHS) providing services to people experiencing anxiety and depression. We recently reported increased service use in the early weeks of the COVID-19 pandemic (19 March to 15 April 2020), and a small increase in anxiety symptoms. This follow-up paper examines trends in service use and symptoms, over 12 weeks from 19 March to 10 June 2020. Demographics, symptoms, and psychosocial stressors were compared for participants starting an online assessment over four time-periods: A baseline "Comparison period" prior to the COVID-19 pandemic (1 to 28 September 2019), "Weeks 1-4" of the COVID-19 pandemic in Australia (19 March-15 April 2020), "Weeks 5-8" (16 April-13 May 2020) and "Weeks 9-12" (14 May-10 June). Responses to questions about the impact of COVID-19 and strategies used by participants to improve their mental wellbeing are also reported. A total of 5455 people started a mental health assessment with MindSpot from 19 March to 10 June 2020. The number of assessments per week rose steadily from 303 in week 1 to a peak of 578 in week 5. Symptoms of anxiety were highest in Weeks 1-4, declining steadily over subsequent weeks. Psychological distress and depression, as measured by the K-10 and PHQ-9 respectively, remained stable. Concern about COVID-19 was highest in the first week then steadily declined during the following weeks. The proportions of participants reporting changes to routine were consistent across the 12 weeks, and most participants reported adopting helpful strategies to improve their mental wellbeing. We observed an initial increase in service use, which reduced over the 12 weeks. The initial rise in anxiety symptoms returned to baseline. Reported concern about the effect of COVID-19 declined steadily over 12 weeks. Symptoms of psychological distress and depression measured by the K-10 and PHQ-9, and the proportion reporting suicidal thoughts and plans did not change, and to date we have not identified indications of a mental health crisis. However, the long-term effects of COVID-19 on the economy and large sections of society are yet to be fully realised, indicating the importance of ongoing monitoring and reporting of trends as indicators of the mental health of the nation.
Sections du résumé
BACKGROUND
BACKGROUND
The MindSpot Clinic, funded by the Australian Government, is a national digital mental health service (DMHS) providing services to people experiencing anxiety and depression. We recently reported increased service use in the early weeks of the COVID-19 pandemic (19 March to 15 April 2020), and a small increase in anxiety symptoms. This follow-up paper examines trends in service use and symptoms, over 12 weeks from 19 March to 10 June 2020.
METHODS
METHODS
Demographics, symptoms, and psychosocial stressors were compared for participants starting an online assessment over four time-periods: A baseline "Comparison period" prior to the COVID-19 pandemic (1 to 28 September 2019), "Weeks 1-4" of the COVID-19 pandemic in Australia (19 March-15 April 2020), "Weeks 5-8" (16 April-13 May 2020) and "Weeks 9-12" (14 May-10 June). Responses to questions about the impact of COVID-19 and strategies used by participants to improve their mental wellbeing are also reported.
RESULTS
RESULTS
A total of 5455 people started a mental health assessment with MindSpot from 19 March to 10 June 2020. The number of assessments per week rose steadily from 303 in week 1 to a peak of 578 in week 5. Symptoms of anxiety were highest in Weeks 1-4, declining steadily over subsequent weeks. Psychological distress and depression, as measured by the K-10 and PHQ-9 respectively, remained stable. Concern about COVID-19 was highest in the first week then steadily declined during the following weeks. The proportions of participants reporting changes to routine were consistent across the 12 weeks, and most participants reported adopting helpful strategies to improve their mental wellbeing.
CONCLUSIONS
CONCLUSIONS
We observed an initial increase in service use, which reduced over the 12 weeks. The initial rise in anxiety symptoms returned to baseline. Reported concern about the effect of COVID-19 declined steadily over 12 weeks. Symptoms of psychological distress and depression measured by the K-10 and PHQ-9, and the proportion reporting suicidal thoughts and plans did not change, and to date we have not identified indications of a mental health crisis. However, the long-term effects of COVID-19 on the economy and large sections of society are yet to be fully realised, indicating the importance of ongoing monitoring and reporting of trends as indicators of the mental health of the nation.
Identifiants
pubmed: 33110762
doi: 10.1016/j.invent.2020.100351
pii: S2214-7829(20)30117-2
pmc: PMC7580521
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100351Informations de copyright
Crown Copyright © 2020 Published by Elsevier B.V.
Déclaration de conflit d'intérêts
N. Titov and B. Dear are authors and developers of the treatment courses used at the MindSpot Clinic but derive no personal or financial benefit from them.
Références
Aust N Z J Psychiatry. 2017 Dec;51(12):1227-1239
pubmed: 27733709
Internet Interv. 2020 Sep;21:100327
pubmed: 32537424
JMIR Ment Health. 2020 Jun 11;7(6):e20696
pubmed: 32490845
Internet Interv. 2020 Apr;20:100317
pubmed: 32289019
Internet Interv. 2018 Jul 26;13:108-115
pubmed: 30206525
Med J Aust. 2020 Nov;213(10):458-464
pubmed: 33107063
J Anxiety Disord. 2020 Apr;71:102211
pubmed: 32179380
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychol Trauma. 2020 Jul;12(5):494-496
pubmed: 32525385
BMC Psychiatry. 2015 Dec 01;15:304
pubmed: 26626712
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Lancet Digit Health. 2020 Nov;2(11):e582-e593
pubmed: 33103097
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941